This one-day symposium will provide a platform for some of the leading names in the field of epigenetics to present their research on the underpinning biology and the discovery of novel therapeutic targets to the development of chemical probes and small molecule inhibitors. The day will comprise of a series of lectures from internationally leading scientists from both academia and industry, and a poster session for discussion and networking. The meeting will provide early stage career researchers with a fundamental understanding of epigenetics and how it relates to the frontiers of drug discovery.
The meeting is aimed at scientists in the industrial and academic fields with a background in epigenetic chemical biology or drug discovery. It is ideally suited to those studying for a postgraduate degree or working in the pharmaceutical or biotechnology industry.
Day 1 - 7th September 2017
- Opening remarks
- Plenary talk: Discovery of Selective Inhibitors for Protein Metltransferases Professor Jian Jin, Icahn School of Medicine (Mount Sinai)
- The Development of non-BET Bromodomain Chemical Probes Dr Phil Humphreys, GlaxoSmithKline
- Flash Presentations from abstracts (4 x 5 min talks)
- Lunch, posters and exhibition
- Small Molecule Designer Libraries targeting HDACs and Bromodomains Professor John Spencer, University of Sussex
- Bump-and-hole and PROTACs Professor Alessio Ciulli, University of Dundee
- Discovery of a potent and selective ATAD2 inhibitor with antiproliferative activity in breast cancer models Dr Jon Winter-Holt, Astra Zeneca
- Refreshment break, posters and exhibition
- Bromodomain Chemical Probes To Explore Epigenetic Pathways Dr Oleg Fedorov, Structural Genomics Consortium
- Plenary talk: Jmj enzymes - more than lysine demethylases Professor Chris Schofield FRS, University of Oxford
- Closing remarks
Venue and Contact
Eli Lilly & Co Ltd
Erl Wood Manor
Please click here for a location map.
If you will be driving to the venue, please click here for directions.
The nearest train station to the venue is Ascot, which is accessible from London Waterloo station.
Tel: +44 (0)20 7598 1561
Early bird fees before Friday 28 July 2017
GB£80 . . . . . . . . . . . . . . . . . SCI Member
GB£30 . . . . . . . . . . . . . . . . . SCI Student Member
GB£110 . . . . . . . . . . . . . . . . Non-Member
Standard fees after Friday 28 July 2017
GB£120 . . . . . . . . . . . . . . . . SCI Member
GB£50 . . . . . . . . . . . . . . . . . SCI Student Member
GB£160 . . . . . . . . . . . . . . . . Non-Member
SCI Platinum Corporate Members receive 25% off the above rates
Become an SCI Member and save on this and future events
See Membership Options
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
For booking terms and conditions click here.
SCI Members attending this meeting are able to claim CPD points.
Prof Jian Jin, Icahn School of Medicine (Mount Sinai), New York, USA
Prof Chris Schofield FRS, University of Oxford, UK
Prof Alessio Ciulli, University of Dundee, UK
Dr Oleg Fedorov, Structural Genomics Consortium, UK
Dr Phil Humphreys, GlaxoSmithKline, UK
Dr Jon Winter, AstraZeneca, UK
Prof John Spencer, University of Sussex, UK
Call for Abstracts
Posters and Flash presentation (5 slides, 5 minutes)
E-mail an abstract of 300 words (max.) indicating title, authors and preference for presentation option to firstname.lastname@example.org by Thursday 24 August 2017. Oral flash presentation slots are limited and will be selected by the organising committee. Travel bursaries will be awarded to individuals selected to give a flash presentation.
Exhibition and Sponsorship
For further information and prices please email email@example.com. Sponsorship opportunities are available.
For more information, please contact: